Esperite Companies

Esperite N.V., listed at Euronext Amsterdam and Paris, is a leading international company in regenerative and predictive medicine established in 2000.

CryoSave AG’s and Salveo Life Sciences S.A.’s principal activity is the collection, processing and storage of adult human stem cells from umbilical cord blood and the umbilical cord itself. The principal activity of the other subsidiaries is the marketing and promotion of this service, except for Output Pharma Services GmbH.

Genoma is the Group’s second business unit active in the fields of proteomics and genomic predictive medicine. This business has been introduced end 2014.

The Group’s R&D division, The Cell Factory, is the third business unit of the Group. The Cell Factory implements its own proprietary new technology for clinical grade production of autologous mesenchymal and stromal stem cells.


The structure below is the situation as per 30 April 2016
Name of subsidiary directly held by ESPERITE N.V. Place of incorporation
CryoSave AG Switzerland
Genoma SA Switzerland
Salveo Life Sciences SA Switzerland
Cryo-Save Italia Srl. Italy
Crio-Cord S.L. Spain
Cryo-Save Serbia d.o.o. Beograd Serbia
Cryo-Save Hungary Kft. Hungary
Tissue Bank Cryo Center Bulgaria AD Bulgaria
Cryo-Save GmbH Germany
Cryo-Save Labs NV Belgium
Cryo-Save Stammzelltechnologie GmbH Austria
Fagite S.A. Greece
Cryo-Save France S.A.S. France
VSB Services Ltd. Hungary
InKaryo Corporation USA
Cryo-Save USA, Inc. USA
Stichting Cryo-Save* The Netherlands
Stichting Cryo-Save Research* The Netherlands
Output Pharma Services GmbH Germany
Cryo-Save Portugal Lda. Portugal
Cryo-Save South Africa Ltd. South Africa
Cryo-Save CZ s.r.o. Czech Republic

* ESPERITE N.V. controls this entity.